Pfizer/Eyetech Macugen Filing Complete; NDA Is Part Of FDA’s “Pilot 1”

The wet age-related macular degeneration product will have a mid-December user fee date; an advisory committee is set for August. The NDA was submitted in “reviewable units” under FDA’s pilot program.